Regenxbio (RGNX) Return on Sales [ROS] (2014 - 2026)
Regenxbio's Return on Sales [ROS] came in at 27.09% for Q2 2026, up 323.35 percentage points from -296.26% a year earlier and up 1331.05 percentage points from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Return on Sales [ROS] (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regenxbio reported Return on Sales [ROS] of -94.08%, up 11.58 percentage points year-over-year; for FY2025, it came in at -94.58%, up 185.46 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of -17.44 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -280.03% in FY2024 (+17.09 pp), -297.12% in FY2023 (-63.92 pp), -233.20% in FY2022 (-267.22 pp) and 34.01% in FY2021 (+111.15 pp).
- The Q2 2026 figure represents the highest quarterly Return on Sales [ROS] since Q4 2021.
- Year-over-year, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of -58.83 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q1 2025 (a gain of 422.43 percentage points), and the weakest in Q1 2026 (a drop of 1317.58 percentage points).
- Business Quant data shows RGNX's Return on Sales [ROS] at -1303.96% (Q1 2026), -189.99% (Q4 2025) and -176.27% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - | -387.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -387.84% |
| Jun 30, 2026 | 27.09% |
| Mar 31, 2026 | -1,303.96% |
| Dec 31, 2025 | -189.99% |
| Sep 30, 2025 | -176.27% |
| Jun 30, 2025 | -296.26% |
| Mar 31, 2025 | 13.62% |
| Dec 31, 2024 | -242.14% |
| Sep 30, 2024 | -256.55% |
| Jun 30, 2024 | -251.34% |
| Mar 31, 2024 | -408.80% |
| Dec 31, 2023 | -287.68% |
| Sep 30, 2023 | -224.67% |
| Jun 30, 2023 | -365.96% |
| Mar 31, 2023 | -345.68% |
| Dec 31, 2022 | -184.31% |
| Sep 30, 2022 | -267.97% |
| Jun 30, 2022 | -191.53% |
| Mar 31, 2022 | -321.93% |
| Dec 31, 2021 | 78.66% |
API Access
Regenxbio Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();